Delivery Order SPE2DB22D1017-SPE2DB25FG2FD

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM4T1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,342.88 Firm Fixed Price Delivery Order contract covers the supply of 4567059370 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a performance period through January 28, 2025. The contract is not designated as a set-aside and represents an open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,368.78 firm fixed-price delivery order is for VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6LUY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,025.33 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 160-25 mg tablets. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.03 firm-fixed-price delivery order is for the supply of 4567610035 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a performance period ending on March 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,307.69, is for the delivery of 4566422561 ! VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14,...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF9ZD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,515.51 firm fixed-price delivery order is for 4,567,887,041 units of the drug Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,917.45 firm fixed-price delivery order is for the supply of 4566477136 VALSARTAN-HCTZ 320-12.5 MG TAB 90S, with an ultimate completion date of November 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB22D1017 and SPE2DB24FF9LS, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,466.09, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of June 13, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award SPE2DB24D2205|SPE2DB25FDWZA was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,656.64 firm fixed price contract is for the delivery of 4566947301 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a type of prescription medication. The contract has an ultimate completion date of January 16, 2025. The award is not designated under any set-aside program....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.58, is for the supply of 4567790861 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is April 4, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG2FD
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FG2FD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,464.33 firm fixed-price delivery order is for the supply of 4568202294 VALSARTAN-HCTZ 160-25 MG TAB 90S, with a performance period through May 12, 2025. The contract is not set-aside and allows for the provision of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026.

Generated 8/8/25, 9:54 AM